| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_225a1d0e1f89de4e53702d5df06696ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecb2358549d99564670ee6811386f28a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8808ca3c4e93f0e23e9b2d0ecf4f5407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff57afda9f56f62edd86b86a72621d5e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-72 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0696 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N27-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0735
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db3a5782cce29670805da583588680bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b4d5a6c497248107c8aa849354e4601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8544eb78decef3be4c75d9190d971dfd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5526666f5a43ca49ddb63e5233e40568 |
| publicationDate |
2013-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013011380-A1 |
| titleOfInvention |
Use of Cytidine Deaminase-Related Agents to Promote Demethylation and Cell Reprogramming |
| abstract |
Methods, compositions and kits for modulating demethylation in a mammalian cell are provided. Also provided are methods, compositions and kits for screening candidate agents for activity in modulating genomic DNA demethylation in mammalian cells. These methods, compositions and kits find use in producing induced pluripotent stem cells (iPS) and somatic cells in vitro and for treating human disorders including cancer and disorders arising from defects in genomic imprinting. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016115447-A1 |
| priorityDate |
2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |